Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ATP5S - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MTR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929500 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGTPBP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MOSPD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HP1BP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DHX15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRFIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SACS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMAD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPG20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPAST - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC63 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHTF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPTLC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on